🇺🇸 FDA
Pipeline program

placebo of BAY 3427080, BAY 3427080

22423

Phase 2 small_molecule active

Quick answer

placebo of BAY 3427080, BAY 3427080 for Sleep disturbances associated with menopause is a Phase 2 program (small_molecule) at Bayer AG with 1 ClinicalTrials.gov record(s).

Program details

Company
Bayer AG
Indication
Sleep disturbances associated with menopause
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials